ClinicalTrialsFinder

Refractory Juvenile Myelomonocytic Leukemia Clinical Trials in Birmingham, Alabama

1 recruitingBirmingham, Alabama

Showing 1–1 of 1 trials

Recruiting
Phase 1

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

Recurrent Childhood Acute Myeloid LeukemiaRecurrent Childhood Myelodysplastic SyndromeRecurrent Juvenile Myelomonocytic Leukemia+3 more
Children's Oncology Group36 enrolled19 locationsNCT06247787